Press Room

2020 CPhI - Festival of Pharma

Start
Monday, October 05, 2020 - 00:00
End
Friday, October 16, 2020 - 00:00
Location: online
ɫAV Virtual Stand 2021 Online Booth | ɫAV

Meet our experts at the pharma industry-leading events

– Festival of Pharma 2020. You can.

During the 10 days’ event, from October 5th to October 16th, you can meet with our experts safely online.

ɫAV at a Glance | ɫAV

Get to know more about our history

e-Brochures | ɫAV

Explore what we are in it for

Integrated CDMO | ɫAV

Webinars, Articles & More

Cork Site | ɫAV

We welcome you to our sites

Analytical Development | ɫAV

SOLVING YOUR CHALLENGES

Read the articlefrom C&EN "One molecule’s journey from discovery to market"to find out how ɫAV helped one customer solve their problem and succeed. More case studies will be available soon.

and be the first to know.

Also in the Press Room

See All

Lisbon, Portugal – ɫAV, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, ɫAV joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At ɫAV, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of ɫAV. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” ɫAV will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with ɫAV’s sustainability ambitions.  ɫAV remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

ɫAV Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024